M/21/079 – Uniphar/NaviCorp
The Competition and Consumer Protection Commission (CCPC) has determined that the proposed acquisition of NaviCorp Limited (trading as Navi Group) by Uniphar PLC may not be put into effect on the grounds that the result of the proposed acquisition will be to substantially lessen competition in markets for services in the State.
|Notification date||Decision date|
|Friday December 24, 2021||Thursday, December 15, 2022|
|Parties Involved||Business activities|
Headquartered in Dublin, Uniphar plc is an Irish-incorporated public limited company traded on Euronext Dublin and the London Stock Exchange. It is an international diversified healthcare services business, servicing the requirements of more than 200 multinational pharmaceutical and medical technology manufacturers across three sectors/divisions - commercial & clinical, product access and supply chain & retail.
NaviCorp Limited is a pharmacy solutions business. Headquartered in Dublin, NaviCorp specialises in product buying and trading, the development of market leading IT systems for use in pharmacies and retail pharmacy franchise services. NaviCorp's group operates under four main divisions, namely (i) brokerage, (ii) technology, (iii) retail and (iv) trading.
|Economic sector||Media merger|
|Other Retail (Pharmacy)||No|
|Submissions from third parties due by:|
|Phase 1||Phase 2|
|Thursday, January 6, 2022||Monday, May 16, 2022|
|Date of Requirement for Information||Date Information Received|
|Friday, May 20, 2022|
|Current status: Completed|
|Authorised Officer Assigned||Contact Details|
Media enquiries: email@example.com